TrialBone marrow transplantation2025

Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trial.

Bhagirathbhai Dholaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.